Last reviewed · How we verify
NCT00359320
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
NA trial testing pancreaticojejunostomy in Pancreatic Neoplasms in 54 participants. Terminated before completion.
12 July 2008
Quick facts
| Lead sponsor | Thomas Jefferson University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 25 May 2006 |
| Primary completion | 12 July 2008 |
| Estimated completion | 12 July 2008 |
| Sites | 1 location across United States |
Drugs / interventions tested
- pancreaticojejunostomy
Conditions studied
- Pancreatic Neoplasms — all drugs for Pancreatic Neoplasms →
- Biliary Tract Neoplasms — all drugs for Biliary Tract Neoplasms →
- Pancreatitis, Chronic — all drugs for Pancreatitis, Chronic →
- Duodenal Neoplasms — all drugs for Duodenal Neoplasms →
Sponsor
Thomas Jefferson University
Who can join
18 and older, any sex, with Pancreatic Neoplasms or Biliary Tract Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this trial is to determine whether a mucosa-to-mucosa technique of pancreaticojejunostomy will improve the pancreatic fistula rate.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.
Berger AC, Howard TJ, Kennedy EP, Sauter PK, et al · · 2009 · cited 227× · PMID 19476827 · DOI 10.1016/j.jamcollsurg.2008.12.031
Verify or expand the search:
- PubMed search for NCT00359320
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of pancreaticojejunostomy
Trials testing the same drug.
- NCT05475275 — Different Pancreaticojejunostomy After Pancreaticoduodenectomy · NA · unknown
- NCT04724174 — Pancreaticogastrostomy for High-Risk Pancreas · completed
Other recruiting trials for Pancreatic Neoplasms
Currently open trials in the same condition.
- NCT07504471 — Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhib · Phase 2 · recruiting
- NCT07139236 — Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD · recruiting
- NCT06885697 — Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi · Phase 1 · recruiting
- NCT06939023 — Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3) · NA · recruiting
- NCT06953193 — Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia · NA · recruiting
Other Thomas Jefferson University trials
Trials by the same sponsor.
- NCT07526480 — Improving Dementia Care in Primary Practice · NA · not yet recruiting
- NCT07414550 — Radiotherapy for Refractory Hidradenitis Suppurativa · NA · not yet recruiting
- NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
- NCT07217197 — Respiratory Monitoring System That Detects & Predicts OIRD · NA · enrolling by invitation
- NCT07145099 — The IMPACT Study: Personalized Physical Therapy for Better Recovery and a Stronger Core After Hernia Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00359320 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Thomas Jefferson University
- Last refreshed: 2 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00359320.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing